Anxiety Disorders: From Bench to Bedside and Beyond

Abstract

The anxiety disorders are common, associated with high comorbidity and cause considerable disability. Despite effective treatment options, they are frequently misdiagnosed, and management is often sub-optimal. With the recent publication of the DSM 5 and the imminent release of the ICD 11, there have been important debates about how best to catagorise and conceptualise these disorders. In addition, their underlying neurobiology is being explored at multiple levels from systems neuroscience to molecular biology and genetics-an endeavor that is delivering key insights with relevance to clinical practice. Furthermore, several international anxiety disorder treatment guidelines have recently been published, and large systematic reviews and meta-analyses have addressed important questions around clinical management. All of this indicates the need for an update on advances in this rapidly developing field, and this chapter therefore provides an overview of the epidemiology and classification, cognitive-affective neuroscience, and clinical management of the anxiety disorders.

Role of Yoga and Meditation as Complimentary Therapeutic Regime for Stress-Related Neuropsychiatric Disorders: Utilization of Brain Waves Activity as Novel Tool

“…2 As a critical neuropsychiatric disorder, anxiety accounts for, on average, 16 to 31% of prevalence rate worldwide. 3 In addition, approximately 3 billion individuals worldwide suffer from tension-type and other forms of headache as per the 2016 report of Global Burden of Disease Study by the Institute of Health Metrics and Evaluation. 4 Exposure to a varied form of stress is the largest contributor to neuropsychiatric disorders.…”